Literature DB >> 22388885

Thrombocytopenia is more severe in patients with chronic hepatitis C than in patients with nonalcoholic fatty liver disease.

Hironori Mawatari, Masato Yoneda, Hiroyuki Kirikoshi, Shin Maeda, Atsushi Nakajima, Satoru Saito.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22388885     DOI： 10.1007/s00535-012-0556-5

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN： 0944-1174            Impact factor:   7.527


× No keyword cloud information.
  7 in total

1.  Thrombocytopenia in chronic hepatitis C.

Authors:  Mihai Olariu; Cristina Olariu; Dan Olteanu
Journal:  J Gastrointestin Liver Dis       Date:  2010-12       Impact factor: 2.008

2.  Thrombocytopenia is more severe in patients with advanced chronic hepatitis C than B with the same grade of liver stiffness and splenomegaly.

Authors:  Kazuaki Tejima; Ryota Masuzaki; Hitoshi Ikeda; Haruhiko Yoshida; Ryosuke Tateishi; Yosuke Sugioka; Yukio Kume; Tomoko Okano; Tomomi Iwai; Hiroaki Gotoh; Sachiko Katoh; Atsushi Suzuki; Yukako Koike; Yutaka Yatomi; Masao Omata; Kazuhiko Koike
Journal:  J Gastroenterol       Date:  2010-03-26       Impact factor: 7.527

3.  Platelet count for predicting fibrosis in nonalcoholic fatty liver disease.

Authors:  Masato Yoneda; Hideki Fujii; Yoshio Sumida; Hideyuki Hyogo; Yoshito Itoh; Masafumi Ono; Yuichiro Eguchi; Yasuaki Suzuki; Noriaki Aoki; Kazuyuki Kanemasa; Kento Imajo; Kazuaki Chayama; Toshiji Saibara; Norifumi Kawada; Kazuma Fujimoto; Yutaka Kohgo; Toshikazu Yoshikawa; Takeshi Okanoue
Journal:  J Gastroenterol       Date:  2011-07-13       Impact factor: 7.527

Review 4.  Classification of chronic hepatitis: diagnosis, grading and staging.

Authors:  V J Desmet; M Gerber; J H Hoofnagle; M Manns; P J Scheuer
Journal:  Hepatology       Date:  1994-06       Impact factor: 17.425

5.  Design and validation of a histological scoring system for nonalcoholic fatty liver disease.

Authors:  David E Kleiner; Elizabeth M Brunt; Mark Van Natta; Cynthia Behling; Melissa J Contos; Oscar W Cummings; Linda D Ferrell; Yao-Chang Liu; Michael S Torbenson; Aynur Unalp-Arida; Matthew Yeh; Arthur J McCullough; Arun J Sanyal
Journal:  Hepatology       Date:  2005-06       Impact factor: 17.425

Review 6.  Thrombocytopenia associated with chronic liver disease.

Authors:  Nezam Afdhal; John McHutchison; Robert Brown; Ira Jacobson; Michael Manns; Fred Poordad; Babette Weksler; Rafael Esteban
Journal:  J Hepatol       Date:  2008-03-31       Impact factor: 25.083

7.  Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD).

Authors:  M Yoneda; M Yoneda; H Mawatari; K Fujita; H Endo; H Iida; Y Nozaki; K Yonemitsu; T Higurashi; H Takahashi; N Kobayashi; H Kirikoshi; Y Abe; M Inamori; K Kubota; S Saito; M Tamano; H Hiraishi; S Maeyama; N Yamaguchi; S Togo; A Nakajima
Journal:  Dig Liver Dis       Date:  2007-12-20       Impact factor: 4.088
  7 in total
  5 in total

1.  Telaprevir-induced, but not pegylated interferon-associated, retinopathy as a noteworthy adverse effect during triple antiviral therapy in patients with chronic hepatitis C.

Authors:  Kayoko Sugawara; Mie Inao; Nobuaki Nakayama; Satoshi Mochida
Journal:  J Gastroenterol       Date:  2013-10-01       Impact factor: 7.527

2.  The Clinical Difference in the Platelet Counts between Liver Cirrhosis with Nonalcoholic Fatty Liver Disease and Hepatitis C Virus.

Authors:  Yuichi Ikarashi; Kazuhisa Kodama; Makiko Taniai; Etsuko Hashimoto; Katsutoshi Tokushige
Journal:  Intern Med       Date:  2017-12-21       Impact factor: 1.271

3.  Nonalcoholic Fatty Liver Disease and Thrombocytopenia III: Its Association With Insulin Resistance.

Authors:  Miguel Antonio López-Trujillo; Jesús Mauricio Olivares-Gazca; Yahveth Cantero-Fortiz; Yarely Itzayana García-Navarrete; Antonio Cruz-Mora; Juan Carlos Olivares-Gazca; Iván Murrieta-Álvarez; Andrés Aurelio León-Peña; Guillermo J Ruiz-Delgado; Guillermo J Ruiz-Argüelles
Journal:  Clin Appl Thromb Hemost       Date:  2019 Jan-Dec       Impact factor: 2.389

4.  Changes in Platelet Counts and Thrombocytopenia Risk in Patients with Chronic Liver Disease with Different Etiologies Using Real-World Japanese Data.

Authors:  Manami Yoshida; Ryosuke Tateishi; Shinzo Hiroi; Masakazu Fujiwara; Yoshitake Kitanishi; Kosuke Iwasaki; Tomomi Takeshima; Ataru Igarashi
Journal:  Adv Ther       Date:  2021-12-20       Impact factor: 3.845

Review 5.  Nonalcoholic fatty liver disease: Diagnostic biomarkers.

Authors:  Fatemeh Hadizadeh; Elham Faghihimani; Peyman Adibi
Journal:  World J Gastrointest Pathophysiol       Date:  2017-05-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.